15-78617110-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000743.5(CHRNA3):c.291A>G(p.Lys97Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.632 in 1,610,160 control chromosomes in the GnomAD database, including 323,844 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.62 ( 30013 hom., cov: 32)
Exomes 𝑓: 0.63 ( 293831 hom. )
Consequence
CHRNA3
NM_000743.5 synonymous
NM_000743.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.731
Publications
54 publications found
Genes affected
CHRNA3 (HGNC:1957): (cholinergic receptor nicotinic alpha 3 subunit) This locus encodes a member of the nicotinic acetylcholine receptor family of proteins. Members of this family of proteins form pentameric complexes comprised of both alpha and beta subunits. This locus encodes an alpha-type subunit, as it contains characteristic adjacent cysteine residues. The encoded protein is a ligand-gated ion channel that likely plays a role in neurotransmission. Polymorphisms in this gene have been associated with an increased risk of smoking initiation and an increased susceptibility to lung cancer. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
CHRNA3 Gene-Disease associations (from GenCC):
- urinary bladder, atony ofInheritance: AR Classification: STRONG Submitted by: Ambry Genetics, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 15-78617110-T-C is Benign according to our data. Variant chr15-78617110-T-C is described in ClinVar as Benign. ClinVar VariationId is 1209767.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.731 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.741 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CHRNA3 | NM_000743.5 | c.291A>G | p.Lys97Lys | synonymous_variant | Exon 4 of 6 | ENST00000326828.6 | NP_000734.2 | |
| CHRNA3 | NM_001166694.2 | c.291A>G | p.Lys97Lys | synonymous_variant | Exon 4 of 6 | NP_001160166.1 | ||
| CHRNA3 | XM_006720382.4 | c.90A>G | p.Lys30Lys | synonymous_variant | Exon 4 of 6 | XP_006720445.1 | ||
| CHRNA3 | NR_046313.2 | n.493A>G | non_coding_transcript_exon_variant | Exon 4 of 8 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CHRNA3 | ENST00000326828.6 | c.291A>G | p.Lys97Lys | synonymous_variant | Exon 4 of 6 | 1 | NM_000743.5 | ENSP00000315602.5 | ||
| CHRNA3 | ENST00000348639.7 | c.291A>G | p.Lys97Lys | synonymous_variant | Exon 4 of 6 | 1 | ENSP00000267951.4 | |||
| CHRNA3 | ENST00000559658.5 | n.291A>G | non_coding_transcript_exon_variant | Exon 4 of 8 | 2 | ENSP00000452896.1 |
Frequencies
GnomAD3 genomes AF: 0.625 AC: 94868AN: 151894Hom.: 29976 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
94868
AN:
151894
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.662 AC: 165601AN: 250308 AF XY: 0.661 show subpopulations
GnomAD2 exomes
AF:
AC:
165601
AN:
250308
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.632 AC: 922035AN: 1458148Hom.: 293831 Cov.: 34 AF XY: 0.633 AC XY: 459598AN XY: 725526 show subpopulations
GnomAD4 exome
AF:
AC:
922035
AN:
1458148
Hom.:
Cov.:
34
AF XY:
AC XY:
459598
AN XY:
725526
show subpopulations
African (AFR)
AF:
AC:
19007
AN:
33422
American (AMR)
AF:
AC:
37002
AN:
44674
Ashkenazi Jewish (ASJ)
AF:
AC:
16773
AN:
26110
East Asian (EAS)
AF:
AC:
22890
AN:
39684
South Asian (SAS)
AF:
AC:
59163
AN:
86130
European-Finnish (FIN)
AF:
AC:
34833
AN:
53204
Middle Eastern (MID)
AF:
AC:
4183
AN:
5760
European-Non Finnish (NFE)
AF:
AC:
690117
AN:
1108912
Other (OTH)
AF:
AC:
38067
AN:
60252
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
15488
30975
46463
61950
77438
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
18462
36924
55386
73848
92310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.625 AC: 94953AN: 152012Hom.: 30013 Cov.: 32 AF XY: 0.626 AC XY: 46528AN XY: 74312 show subpopulations
GnomAD4 genome
AF:
AC:
94953
AN:
152012
Hom.:
Cov.:
32
AF XY:
AC XY:
46528
AN XY:
74312
show subpopulations
African (AFR)
AF:
AC:
23259
AN:
41448
American (AMR)
AF:
AC:
11510
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
2213
AN:
3470
East Asian (EAS)
AF:
AC:
2891
AN:
5150
South Asian (SAS)
AF:
AC:
3263
AN:
4824
European-Finnish (FIN)
AF:
AC:
6854
AN:
10550
Middle Eastern (MID)
AF:
AC:
228
AN:
292
European-Non Finnish (NFE)
AF:
AC:
42802
AN:
67964
Other (OTH)
AF:
AC:
1391
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
1835
3669
5504
7338
9173
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
772
1544
2316
3088
3860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2233
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
Urinary bladder, atony of Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.